ProKidney Corp. (PROK)
NASDAQ·Healthcare·Biotechnology
$1.84
-1.34%
Mkt Cap $561.66M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 18, 2026 | $600 | $223.00K | +37066.67% | -$0.16 | -$0.14 | +12.50% | — | — |
| Q4 2025 Nov 10, 2025 | — | $217.00K | — | -$0.12 | -$0.12 | +0.00% | — | — |
| Q3 2025 Aug 12, 2025 | $44.25K | $221.00K | +399.44% | -$0.14 | -$0.13 | +7.14% | — | — |
| Q2 2025 May 12, 2025 | — | $230.00K | — | -$0.16 | -$0.13 | +18.75% | — | — |
| Q1 2025 Mar 17, 2025 | — | $76.00K | — | -$0.14 | -$0.17 | -21.43% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.14 | -$0.14 | +0.00% | — | — |
| Q3 2024 Aug 9, 2024 | — | — | — | -$0.17 | -$0.16 | +5.88% | — | — |
| Q2 2024 May 10, 2024 | — | — | — | -$0.25 | -$0.16 | +36.00% | — | — |
| Q1 2024 Mar 21, 2024 | — | $4.49M | — | -$0.19 | -$0.09 | +52.63% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.19 | -$0.18 | +5.26% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.41 | -$0.14 | +65.85% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.39 | -$0.16 | +58.97% | — | — |
| Q1 2023 Mar 28, 2023 | — | — | — | -$0.24 | -$0.11 | +54.17% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.05 | -$0.13 | -160.00% | — | — |
| Q3 2022 Aug 12, 2022 | — | — | — | — | -$0.36 | — | — | — |
| Q2 2022 May 16, 2022 | — | — | — | — | -$2.12 | — | — | — |
| Q1 2022 Mar 24, 2022 | — | — | — | — | -$0.43 | — | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | — | -$0.54 | — | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | — | -$0.40 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.36 | — | — | — |